INKT
Mink Therapeutics Inc
12.20$
-1.9%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -39.0% | +51.4% | +49.7% | -28.6% | -22.4% | -25.4% | -41.8% | +502.3% | -4.8% | -27.1% | -7.3% | |
| – | -44.4% | +66.7% | +57.9% | -30.6% | -24.1% | -28.2% | -43.8% | +622.7% | -4.7% | -27.6% | -7.2% | |
| – | -47.4% | +72.8% | +60.1% | -32.1% | -27.7% | -29.3% | -48.0% | +749.1% | -6.4% | -28.7% | -7.5% | |
| – | -47.4% | +72.8% | +60.1% | -32.1% | -27.7% | -29.3% | -48.0% | +749.1% | -6.4% | -28.7% | -7.5% | |
| – | +7.4% | +20.3% | -1.1% | -7.3% | +1.5% | +3.0% | +6.2% | +2.9% | 0.0% | -19.0% | +2.5% | |
| – | +9.7% | -2.6% | -8.7% | -27.1% | -5.9% | +74.1% | +8.6% | +2.1% | -3.0% | -44.1% | +3.9% | |
| – | – | – | – | – | – | – | +7.6% | +4.0% | -9.5% | – | – | |
| – | -8.6% | -10.9% | -8.2% | -26.3% | +15.5% | -2.5% | +24.6% | +11.4% | -7.3% | -1.0% | +15.5% | |
| – | – | – | +4.6% | +4.7% | +6.8% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.2% | +0.2% | +7.2% | +6.4% | -4.6% | +5.1% | +0.4% | +11.6% | -3.9% | +12.4% | +4.7% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.